30 Sept 2026, 2:50 pmAGM/EGM
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
AGM PDF
Genpharmasec Ltd operates in Trading & Distributors within the Industrials sector.
1,790 historical price candles were omitted because the exchange source has not been verified.
No positive flags triggered.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Consolidated figures
| Ratio | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Margins | |||
| Gross margin % | 20.3% | 12.4% | 8.1% |
| EBITDA margin % | 0.2% | 0.2% | 0.9% |
| EBIT margin % | 0% | -2.2% | -0.7% |
| PAT margin % | -0.6% | 3.7% | 0.4% |
| Working capital | |||
| Receivable days | 109 | 147 | 76 |
| Inventory days | 133 | 101 | 39 |
| Payable days | 36 | 102 | 90 |
| NWC days | 207 | 146 | 26 |
| Leverage | |||
| Current ratio | 15.13 | 2.86 | 1.71 |
| Debt to EBITDA | 64.2 | 52.5 | 26.8 |
| Debt to equity | 0.05 | 0.05 | 0.5 |
| Interest coverage | 1.6 | 5.4 | 1.8 |
| Asset turnover | 0.43 | 0.42 | 1.01 |
| Return ratios | |||
| Return on assets % | -0.2% | 1.5% | 0.4% |
| Return on capital employed % | 1% | 3.3% | 2.8% |
| Return on equity % | -0.3% | 1.9% | 0.8% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
No scheme among the 32 fund houses on record reported a position in Genpharmasec Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
Documents link to external sources (exchange filings, company investor pages).
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Redington LimitedREDINGTONREDINGTON | ₹31,112 Cr | ₹33,749 Cr | ₹1,28,133 Cr | ₹2,537 Cr | 1.9% | ₹1,701 Cr | 1.1% | 21.7% | 15.8% | 34 |
| Mmtc LimitedMMTCMMTC | ₹8,444 Cr | ₹8,444 Cr | ₹3 Cr | ₹-179 Cr | — | ₹447 Cr | — | -0.5% | 20.3% | -2,38,864 |
| Mstc LimitedMSTCLTDMSTCLTD | ₹4,969 Cr | ₹5,114 Cr | ₹386 Cr | ₹236 Cr | 60.6% | ₹234 Cr | 59.1% | 34.9% | 26.6% | -92 |
| Bn Agrochem LimitedBNAGROCHEMBNAGROCHEM | ₹2,228 Cr | ₹2,310 Cr | ₹299 Cr | ₹-37 Cr | -12.5% | ₹20 Cr | 6.6% | 12% | 8.5% | 130 |
| Creative Newtech LimitedCNLCNL | ₹1,619 Cr | ₹1,943 Cr | ₹2,783 Cr | ₹99 Cr | 3.2% | ₹74 Cr | 2.6% | 29.2% | 21.4% | 75 |
| Pervasive Commodities LtdPERVASIVEPERVASIVE | ₹1,090 Cr | ₹1,090 Cr | ₹43 Cr | ₹-0 Cr | -1.1% | ₹-0 Cr | -0.1% | 0% | -0.1% | 548 |
| RRP Defense LtdRRPDEFENSERRPDEFENSE | ₹842 Cr | ₹844 Cr | ₹12 Cr | ₹-1 Cr | -8.4% | ₹-1 Cr | -8.2% | -13.7% | -13.7% | -15 |
| The Yamuna Syndicate LtdYSLYSL | ₹779 Cr | ₹779 Cr | ₹69 Cr | ₹2 Cr | 2.2% | ₹52 Cr | 75.3% | 0.3% | 4% | 60 |
| The State Trading Corporation Of India LimitedSTCINDIASTCINDIA | ₹636 Cr | ₹1,811 Cr | ₹0 Cr | ₹-46 Cr | — | ₹21 Cr | — | — | — | — |
| SMT Engineering LtdSMTELSMTEL | ₹598 Cr | ₹679 Cr | ₹162 Cr | ₹41 Cr | 25% | ₹23 Cr | 14.2% | 33.2% | 25.2% | 395 |
| Bijoy Hans LtdARVAYAARVAYA | ₹576 Cr | ₹579 Cr | ₹0 Cr | ₹-1 Cr | — | ₹0 Cr | — | -3.9% | -3.9% | — |
| Riddhi Siddhi Gluco Biols LtdRIDDHIRIDDHI | ₹505 Cr | ₹787 Cr | ₹236 Cr | ₹-12 Cr | -5.2% | ₹61 Cr | -5.2% | 2.8% | -0.8% | 65 |
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Shareholder Meeting / Postal Ballot-Outcome of AGM
Announcement under Regulation 30 (LODR)-Newspaper Publication
Reg. 34 (1) Annual Report.
Notice Of The 34Th Annual General Meeting Of The Company To Be Held On September 29, 2026.
Intimation Of Book Closure For The Purpose Of AGM
Announcement under Regulation 30 (LODR)-Change in Management
Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday, 02Nd September, 2026.
| Date | Category | Subject | Filing |
|---|---|---|---|
| 30 Sept 2026, 2:50 pm | AGM/EGM AGM | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | |
| 29 Sept 2026, 2:59 pm | AGM/EGM AGM | Shareholder Meeting / Postal Ballot-Outcome of AGM |
| 8 Sept 2026, 11:48 am | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 7 Sept 2026, 12:59 pm | Others Reg. 34 (1) Annual Report | Reg. 34 (1) Annual Report. |
| 7 Sept 2026, 12:43 pm | AGM/EGM AGM | Notice Of The 34Th Annual General Meeting Of The Company To Be Held On September 29, 2026. |
| 2 Sept 2026, 3:56 pm | Corp. Action Book Closure | Intimation Of Book Closure For The Purpose Of AGM |
| 2 Sept 2026, 3:52 pm | Company Update Change in Management | Announcement under Regulation 30 (LODR)-Change in Management |
| 2 Sept 2026, 3:49 pm | Board Meeting Outcome of Board Meeting | Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday, 02Nd September, 2026. |
| Holder (%) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59.96% | 59.96% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | |
| FII | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DII | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 40.04% | 40.04% | 70.02% | 70.02% | 70.02% | 70.02% | 70.02% | 70.02% | 70.02% | 70.02% | 70.02% | 70.02% | |
| No. of shareholders | — | — | — | — | — | — | — | — | 1,05,804 | 1,04,021 | 1,02,252 | 1,01,134 |
Promoter holding down 29.98 percentage points since Sep 2023.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 31 Aug 2026 | RAJESH MIRCHUMAL SADHWANI | Bulk | BSE | Buy | 40,00,000 | ₹1.05 | ₹0.42 Cr |
| 28 Aug 2026 | RAJESH MIRCHUMAL SADHWANI | Bulk | BSE | Buy | 50,00,000 | ₹1.01 | ₹0.51 Cr |
| 30 Dec 2024 | DIVYA DEVEN PATHAK | Bulk | BSE | Sell | 35,00,000 | ₹2.95 | ₹1.03 Cr |
| 4 Sept 2024 | MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | Bulk | BSE | Sell | 28,57,581 | ₹3.31 | ₹0.95 Cr |
| 3 Sept 2024 | MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | Bulk | BSE | Buy | 30,57,693 | ₹3.18 | ₹0.97 Cr |
| 3 Sept 2024 | MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | Bulk | BSE | Sell | 9,31,149 | ₹3.27 | ₹0.30 Cr |
| 30 Aug 2024 | ISHAAN TRADEFIN LLP | Bulk | BSE | Buy | 45,00,000 | ₹3.71 | ₹1.67 Cr |
| 30 Aug 2024 | ISHAAN TRADEFIN LLP | Bulk | BSE | Sell | 45,00,000 | ₹3.87 | ₹1.74 Cr |
| 30 Aug 2024 | MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED | Bulk | BSE | Buy | 34,00,003 | ₹3.78 | ₹1.29 Cr |
| 27 Aug 2024 | STALLION WEALTH MANAGEMENT LLP | Bulk | BSE | Buy | 60,50,000 | ₹3.36 | ₹2.03 Cr |
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
Consolidated figures · ₹ crore
| ₹ Cr | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| 30 | 34 | 140 | |
| COGS | 24 | 30 | 129 |
| Gross profit | 6 | 4 | 11 |
| 6 | 4 | 10 | |
| 0 | 0 | 1 | |
| OPM % | 0.2% | 0.2% | 0.9% |
| Depreciation | 0 | 1 | 2 |
| Interest | 0 | 0 | 1 |
| 1 | 3 | 3 | |
| Profit before tax | 0 | 2 | 1 |
| Tax | 0 | 1 | 0 |
| Tax % | 168% | 34.6% | 42.3% |
| -0 | 1 | 1 | |
| PAT margin % | -0.6% | 3.7% | 0.4% |
| EPS (₹) | 0 | 0 | 0 |
| EPS adjusted (₹) | -0 | 0 | 0 |
| Annual report | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity capital | 55 | 55 | 55 |
| Reserves | 9 | 10 | 11 |
| Minority interest | 0 | 0 | — |
| 3 | 3 | 33 | |
| 3 | 11 | 39 | |
| Total equity & liabilities | 71 | 80 | 138 |
| 1 | 6 | 39 | |
| CWIP | 0 | 0 | 0 |
| Investments | 19 | 19 | 2 |
| 51 | 55 | 97 | |
| Total assets | 71 | 80 | 138 |
| ₹ Cr | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| -4 | 3 | -18 | |
| -27 | -15 | 13 | |
| 48 | -1 | 4 | |
| Net cash flow | 17 | -14 | -0 |
| Free cash flow | -4 | -3 | -18 |
| CFO / Operating profit % | — | — | — |